U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5687752

Dining Table Having Integral Dishwasher

A space-saving dishwasher, which may be installed within a counter top or table, having a dish-carrying rack that is vertically shiftable through the open top of the dishwasher for facilitating loading and unloading of the dishes.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 549/475 - Chalcogen bonded directly to the hetero ring


Subclass of Class 549 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein chalcogen (i.e., oxygen, sulfur, selenium,
No. of applications: 51
Last issue date: 03/22/2012


1    
Application No.Application TitleIssue Date
20120071426METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER
The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds....
03/22/2012
20120022100ORGANIC COMPOUNDS
Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I)

and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising thes...

01/26/2012
20110309300COMPOUND HAVING A FIVE-MEMBERED RING, THE LIQUID CRYSTAL COMPOSITION AND THE LIQUID CRYSTAL DISPLAY DEVICE
The invention provides a liquid crystal compound that has an excellent compatibility with other liquid crystal compounds and also has at least one of characteristics such as a high stability to heat, light or the like, a suitable refractive index anisotropy (Δn), a low...
12/22/2011
20110269677Oligomer-Protease Inhibitor Conjugates
The invention provides protease inhibitors that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the ...
11/03/2011
20110263556New Compounds
This invention relates to compounds of formula I,

their use as inhibitors of the microsomal prostaglandin E2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medi...

10/27/2011
20110195939ANTITUMOR PROPERTIES OF NO MODIFIED PROTEASE INHIBITORS
HIV-protease inhibitors, particularly saquinavir, showed strong anticancer activity but numerous side effects limited its application. In order to overcome its toxicity original compounds were modified by covalent attachment of NO. The efficacy of parental and NO-modifi...
08/11/2011
20110178165TETRAHYDROFURANYL SULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I): as defined in the specification. The invention is also directed to compositions containing the compounds of formula ...
07/21/2011
20110105533Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I:

as defined in the specification. The invention is also d...

05/05/2011
20100292373ADDUCTS OF LEVULINIC DERIVATIVES WITH EPOXIDIZED FATTY ACID ESTERS AND USES THEREOF
The present disclosure relates to methods of preparation of compounds resulting from the reaction of levulinic esters and epoxidized unsaturated fatty acid esters. The compounds are useful as renewable biomass-based plasticizers for a variety of polymers. Mono-, di- and...
11/18/2010
20100285500NEUROFURANS-INDICES OF OXIDANT STRESS
The invention is drawn to a new class of isoeicosanoids that have been identified as products of the oxidation of docosahexaenoic acid (DHA). The invention provides compositions and methods related to the new class of molecules....
11/11/2010
20100240879PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATES AND INTERMEDIATES THEREIN
The present invention relates to processes for preparing the compounds of general formula I,

wherein the groups R1 and R3 are defined according to claim 1. Furthermore this invent...

09/23/2010
20100222603Glyceryl Ether Compounds and their Use
Glyceryl ether compounds prepared by the reaction of glycerol and olefin epoxides are disclosed. The compounds are renewable biomass-based surfactants useful as detergents and emulsifiers in formulations for cleaning, laundry, personal care, cosmetics, and industrial us...
09/02/2010
20100168422METHODS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HEXAHYDROFURO [2,3-B]FURAN-3-OL
Provided herein are compounds and methods useful for preparing hexahydrofuro[2,3-b]furan-3-ol. Hexahydrofuro[2,3-b]furan-3-ol can be efficiently synthesized in four steps from readily available starting materials....
07/01/2010
20100124543SULPHONAMIDE DERIVATIVES AS PRODRUGS OF ASPARTYL PROTEASE INHIBITORS
The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high or...
05/20/2010
20100125144HYDROGENATION OF ESTERS WITH RU/TETRADENTATE LIGANDS COMPLEXES
The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of Ru complexes with tetradentate ligands having at least one amino or imino coordinating group and at least one phosphino coordinating group in hydrogenation proces...
05/20/2010
20100111890USE IN PERFUMERY AND FLAVORING AND PROCESS FOR THE PREPARATION OF 5,5-DIMETHYL-3-ETHYL-3,4-DIHYDROFURAN-2-ONE
The invention relates to the use of 5,5-dimethyl-3-ethyl-3,4-dihydrofuran-2-one (A), named “Noxolide” by the applicant, as an olfactory agent in perfumery, and also as a food flavouring. The invention also relates to a novel process for the preparation of 5,5-dimeth...
05/06/2010
20100094028METHODS FOR THE PREPARATION OF HEXAHYDROFURO[2,3-b]FURAN-3-OL
Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol and especially its enantiomer (3R,3aS,6aR) hexahydrofuro[2,3-b]furan-3-ol, as well as certain novel intermediates for use in such methods....
04/15/2010
20100056808PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN
Fused cyclopentane—4-substituted 3,5-dioxalane lactone compounds useful as an intermediate in the synthesis of prostaglandin analogs are provided. The compounds have the formula A:

wherein R represents an a...

03/04/2010
20090208552CROSS-LINKED FATTY ACID-BASED BIOMATERIALS
Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and ...
08/20/2009
20090198065RESIST POLYMER, RESIST COMPOSITION, PROCESS FOR PATTERN FORMATION, AND STARTING COMPOUNDS FOR PRODUCTION OF THE RESIST POLYMER
To provide a resist polymer comprising, as a structural unit, an acid-decomposable unit having a structure represented by formula (1) or (2) which exhibits a small line edge roughness and produces little defects in DUV excimer laser lithography or the like.

08/06/2009

20090176836Cyclic Ketal Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
The present invention is directed to cyclic ketal compounds of formula (I)

which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme...

07/09/2009
20090176859Cathepsin cysteine protease inhibitors
The present invention relates to a novel class of compounds mainly, leucinamide-amino-carboxylate derivatives of formula (I) wherein Y is CR1R2, O, S, —SO2, C=0 or NR9; Z is CR1R2, O, S, —SO2
07/09/2009
20090076062Organic Compounds
Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I)

and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising thes...

03/19/2009
20090053710FUNCTIONAL MOLECULE, FUNCTIONAL MOLECULE SYNTHESIZING AMIDITE AND TARGET SUBSTANCE ANALYSIS METHOD
To provide a functional molecule including a modified nucleotide unit having a substituent introduced to a base thereof, wherein the substituent is removably introduced to the base; a functional molecule synthesizing amidite that has a substituent removably introduced t...
02/26/2009
20090005581Method for Preparing 3-Hydroxytetrahydrofuran Using Cyclodehydration
Disclosed is a method of preparing 3-hydroxytetrahydrofuran using cyclodehydration. More particularly, this invention relates to a method of preparing 3-hydroxytetrahydrofuran, including subjecting 1,2,4-butanetriol to cyclodehydration under reaction conditions of a rea...
01/01/2009
20080275016FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are fulvene and/or fulvalene analogs. The compounds and compositions can be used to treat and/or prevent a wide variety of cancers, in...
11/06/2008
20080108816PROCESS FOR THE PREPARATION OF (S)-4-FLUOROMETHYL-DIHYDRO-FURAN-2-ONE
The present invention relates to a process of the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one of the formula
by employing a dialkylmalonate of the formula
wherein R1b is lower alkyl, and the use of this process for the manufacture...
05/08/2008
20080085928Sulfonamide derivatives
Compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof, wherein L, R1, R2, m and n have the meaning given in claim 1 and which can be used in the form of pharmaceutical compositions. ...
04/10/2008
20080071098HYDROGENATION OF ESTERS WITH RU/TETRADENTATE LIGANDS COMPLEXES
The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of Ru complexes with tetradentate ligands having at least one amino or imino coordinating group and at least one phosphino coordinating group in hydrogenation proces...
03/20/2008
20080071084Method for preparing alkyl ethers and aryl ethers
Method for preparing compounds of the formula (III) by reacting compounds of the formula (II) with a) an alcoholate or b) an alcohol R1-OH and a base

in the presence of a Cu-containing catalyst and of a ligan...

03/20/2008
20080070910Therapeutic compounds and methods
The present invention provides compounds of Formula (I):
wherein A, X, Q, R2-R6, m, and W have the values described herein, as well as compositions comprising such compounds. The compounds are protease inhibitors and are useful for inhibi...
03/20/2008
200800648742-Halofuryl/Thienyl-3-Carboxamides
Novel 2-halofuryl/thienyl-3-carboxamides of the formula (I)

in which

  • A, Hal, R, M and Z are as defined in the description,
    a plural...
03/13/2008
20080045516Viral Polymerase Inhibitors
Compounds of formula I:
wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase. ...
02/21/2008
20080021222Processes for preparing biaryl ureas and analogs thereof
The present invention relates to processes for preparing biaryl ureas derivatives and analogs thereof. The invention also provides compounds useful as intermediates in the processes of the present invention. The process is useful for preparing compounds that inhibit IMP...
01/24/2008
20080021201Protease inhibitor conjugates and antibodies useful in immunoassay
Activated haptens useful for generating immunogen to HIV protease inhibitors, immunogens useful for producing antibodies to HIV protease inhibitors, and antibodies and labeled conjugates useful in immunoassays for the HIV protease inhibitor saquinavir. The novel haptens...
01/24/2008
20080015366Protected 5,7-Dihydroxy-4,4-Dimethyl-3-Oxoheptanoic Acid Esters and 5,7-Dihydroxy-2-Alkyl-4,4-Dimethyl-3-Oxoheptanoci Acid Esters for the Synthesizing of Epothilone and Epothilone Derivatives and Process for the Production of These Esters
This invention describes protected 5,7-dihydroxy-4,4-dimethyl-3-oxoheptanoic acid ester and 5,7-dihydroxy-2-alkyl-4,4-dimethyl-3-oxoheptanoic acid ester for the synthesis of epothilones and epothilone derivatives and process for the production of these esters....
01/17/2008
20080008965Ester compounds and their preparation, polymers, resist compositions and patterning process
Novel ester compounds having formulae (1) to (4) wherein A1 is a polymerizable functional group having a carbon-carbon double bond, A2 is oxygen, methylene or ethylene, R1 is a monovalent hydrocarbon group, R2 is H or a monova...
01/10/2008
20070265231Hydrazide Compounds for Combating Animal Pests
The present invention relates to new hydrazide compounds which are useful for combating animal pests, in particular insects, arachnids and nematodes and to the salts thereof. The invention also relates to a method for combating insects, nematodes and arachnids. The hydr...
11/15/2007
20070220688Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds
The present invention provides α-hydroxy benzeneacetic acid derivatives of the formula as defined in the specification which is a precursor indispensable for synthesis of compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus, and a ...
09/27/2007
200701617014-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
System for selecting a colour shade comprising a very small number of colour display cards with mixed shades of two or more colours. The system comprises means for selecting one shade among mixed shades, means for presenting the selected mixed shade as well as means for...
07/12/2007
1    
 
Sign InRegister
Username  
Password   
forgot password?